MPP Facilitates Agreements With Seven Manufacturers For COVID-19 Antiviral
Agreement On Ensitrelvir With Shionogi Represents MPP’s First Deal With A Japanese Firm
The Medicines Patent Pool has facilitated sublicenses with seven manufacturers to distribute generic versions of Shionogi’s oral COVID-19 antiviral ensitrelvir across low- and middle-income countries.
